Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Low-Dose Bevacizumab Versus Laser for Type 1 Retinopathy of Prematurity

NCT04634604 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT04634604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04634604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Low-Dose Bevacizumab Versus Laser for Type 1 Retinopathy of Prematurity
Lead sponsor
Jaeb Center for Health Research
Phase
Phase 3
Overall status
Terminated
Start date
April 27, 2022
Completion date
August 14, 2023
Enrollment
16 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

retinopathy of prematurity